CellaVision AB (publ)
CLVSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $723 | $677 | $639 | $566 |
| % Growth | 6.8% | 5.9% | 13% | – |
| Cost of Goods Sold | $236 | $214 | $201 | $173 |
| Gross Profit | $487 | $463 | $438 | $392 |
| % Margin | 67.3% | 68.4% | 68.6% | 69.4% |
| R&D Expenses | $87 | $83 | $89 | $64 |
| G&A Expenses | $85 | $76 | $74 | $63 |
| SG&A Expenses | $222 | $213 | $191 | $165 |
| Sales & Mktg Exp. | $137 | $137 | $118 | $102 |
| Other Operating Expenses | -$0 | $0 | $0 | -$0 |
| Operating Expenses | $309 | $296 | $280 | $230 |
| Operating Income | $178 | $167 | $158 | $163 |
| % Margin | 24.6% | 24.7% | 24.8% | 28.8% |
| Other Income/Exp. Net | -$1 | -$3 | -$10 | -$4 |
| Pre-Tax Income | $177 | $164 | $148 | $158 |
| Tax Expense | $36 | $34 | $30 | $33 |
| Net Income | $141 | $130 | $118 | $125 |
| % Margin | 19.5% | 19.2% | 18.5% | 22.2% |
| EPS | 5.9 | 5.46 | 4.96 | 5.25 |
| % Growth | 8.1% | 10.1% | -5.5% | – |
| EPS Diluted | 5.9 | 5.46 | 4.96 | 5.25 |
| Weighted Avg Shares Out | 24 | 24 | 24 | 24 |
| Weighted Avg Shares Out Dil | 24 | 24 | 24 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $0 | $0 |
| Interest Expense | $2 | $3 | $2 | $2 |
| Depreciation & Amortization | $41 | $40 | $40 | $33 |
| EBITDA | $220 | $207 | $191 | $194 |
| % Margin | 30.4% | 30.6% | 29.9% | 34.2% |